Meilleure Health International Industry Group Limited provided preliminary consolidated earnings guidance for the year ended 31 December 2023. Based on the preliminary review of the unaudited consolidated management accounts of the Group for the year ended 31 December 2023 and the information currently available to the Company, the Group expects to record a profit attributable to the Shareholders in the range of approximately HKD 38 million to HKD 43.8 million for the year ended 31 December 2023 as compared to a profit attributable to the Shareholders of approximately HKD 17.8 million for the year ended 31 December 2022.
Meilleure Health International Industry Group Limited
Equities
2327
BMG5975D1048
Construction Materials
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.145 HKD | -.--% | +19.83% | -41.06% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.06% | 75.87M | |
+5.57% | 4.06B | |
-13.39% | 937M | |
-.--% | 538M | |
-16.09% | 509M | |
-3.39% | 476M | |
-12.13% | 440M | |
-0.60% | 272M | |
+0.65% | 255M | |
+18.42% | 230M |
- Stock Market
- Equities
- 2327 Stock
- News Meilleure Health International Industry Group Limited
- Meilleure Health International Industry Group Limited Provides Preliminary Consolidated Earnings Guidance for the Year Ended 31 December 2023